The speaker will explore:
- The Rise of Biomarker-Driven Therapies: The attendees will get to understand how biomarkers are revolutionizing cancer treatment by offering targeted therapies that align with specific cancer subtypes. They will also learn about the pivotal role of biomarkers like human epidermal growth factor receptor 2 (HER2) in breast cancer and their impact on therapy development
- Shifting Dynamics in Drug Development: The attendees will get to discover how biomarker-driven approaches are streamlining drug development, reducing time to approval and increasing the success rates of new therapies. They will also get to explore the collaborative efforts between pharmaceutical companies and diagnostic labs that are expediting this process
- The Changing Role of Diagnostic Labs: The attendees will also get to examine how diagnostic labs have transitioned from service providers to proactive partners in oncology care. They will also get to learn about their early involvement in clinical trials and the development of companion diagnostics, ensuring accurate and timely treatment allocation
This webinar will highlight the collaborative synergy among pharmaceutical companies, diagnostic labs and healthcare providers, emphasizing the integrated approach necessary for advancing patient care. The speaker will discuss real-world examples and case studies, providing attendees with a comprehensive understanding of how precision medicine is reshaping the future of oncology. He will offer valuable insights into the dynamic role of diagnostic labs in the era of precision medicine and explore the promises and challenges that lie ahead on collectively driving better outcomes for cancer patients.
Register for this webinar today that will delve into the transformative impact of precision medicine on oncology care and highlight the evolving role of diagnostic labs in the era of biomarker-driven therapies.
Join Dr. Yuri Fesko, MD, Chief Medical Officer, Quest Diagnostics, for the live webinar on Monday, September 16, 2024, at 1pm EDT (10am PDT).
For more information, or to register for this event, visit Advancing Oncology Care: The Evolving Role of Diagnostic Labs in Biomarker-Driven Therapies.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Soumya Shashikumar, Xtalks, +1 (416) 977-6555 x371, [email protected] , https://xtalks.com
SOURCE Xtalks
